Table 7 Supplemental oxygen delivery modalities, stratified by medications. Abbreviations: BiPAP, bilevel positive airway pressure; CPAP, continuous positive airway pressure; ECMO, extracorporeal membrane oxygenation
Azithro-mycin | Cortico-steroids | Hydroxy-chloroquine | Remdesivir | Tocilizumab | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Early (N = 2539) | Late (N = 5341) | Early (N = 2711) | Late (N = 11,050) | Early (N = 1436) | Late (N = 143) | Early (N = 1013) | Late (N = 5852) | Early (N = 650) | Late (N = 451) | Total (N = 9,638) | |
Non-Invasive Ventilation Measures | 2,303 (90.71%) | 4,917 (92.06%) | 2,516 (92.81%) | 10,232 (92.60%) | 1,299 (90.46%) | 137 (95.80%) | 972 (95.95%) | 5,601 (95.71%) | 614 (94.46%) | 433 (96.01%) | 8,709 (90.36%) |
Nasal Oxygen Cannula | 2,200 (86.65%) | 4,709 (88.17%) | 2,416 (89.12%) | 9,805 (88.73%) | 1,241 (86.42%) | 135 (94.41%) | 945 (93.29%) | 5,401 (92.29%) | 586 (90.15%) | 401 (88.91%) | 8,375 (86.90%) |
Oxygen Mask | 1,290 (50.81%) | 2,635 (49.34%) | 1,602 (59.09%) | 5,917 (53.55%) | 809 (56.34%) | 72 (50.35%) | 651 (64.26%) | 3,370 (57.59%) | 446 (68.62%) | 305 (67.63%) | 4,935 (51.20%) |
BiPAP | 583 (22.96%) | 2,485 (46.53%) | 880 (32.46%) | 5,245 (47.47%) | 244 (16.99%) | 72 (50.35%) | 372 (36.72%) | 3,070 (52.46%) | 249 (38.31%) | 283 (62.75%) | 2,955 (30.66%) |
CPAP | 171 (6.73%) | 622 (11.65%) | 272 (10.03%) | 1,491 (13.49%) | 86 (5.99%) | 18 (12.59%) | 119 (11.75%) | 833 (14.23%) | 71 (10.92%) | 65 (14.41%) | 872 (9.05%) |
Invasive Ventilation | 1,233 (48.56%) | 2,509 (46.98%) | 1,515 (55.88%) | 5,699 (51.57%) | 871 (60.65%) | 89 (62.24%) | 536 (52.91%) | 3,026 (51.71%) | 444 (68.31%) | 316 (70.07%) | 4,833 (50.15%) |
Tracheo-stomy | 66 (2.60%) | 176 (3.30%) | 97 (3.58%) | 394 (3.57%) | 40 (2.79%) | 10 (6.99%) | 44 (4.34%) | 212 (3.62%) | 22 (3.38%) | 21 (4.66%) | 303 (3.14%) |
ECMO | 14 (0.55%) | 28 (0.52%) | 33 (1.22%) | 101 (0.91%) | 15 (1.04%) | 0 (0.00%) | 23 (2.27%) | 48 (0.82%) | 10 (1.54%) | 7 (1.55%) | 106 (1.10%) |